-
1
-
-
24644445302
-
The human genome project and novel aspects of cytochrome P450 research
-
Ingelman-Sundberg M, (2005) The human genome project and novel aspects of cytochrome P450 research. Toxicology and applied pharmacology 207: 52-56.
-
(2005)
Toxicology and Applied Pharmacology
, vol.207
, pp. 52-56
-
-
Ingelman-Sundberg, M.1
-
2
-
-
84855600289
-
Retrospective drug utilization review: impact of pharmacist interventions on physician prescribing
-
Angalakuditi M, Gomes J, (2011) Retrospective drug utilization review: impact of pharmacist interventions on physician prescribing. ClinicoEconomics and outcomes research: CEOR 3: 105-108.
-
(2011)
ClinicoEconomics and Outcomes Research: CEOR
, vol.3
, pp. 105-108
-
-
Angalakuditi, M.1
Gomes, J.2
-
4
-
-
75149194970
-
Progress towards personalized medicine
-
Bates S, (2010) Progress towards personalized medicine. Drug discovery today 15: 115-120.
-
(2010)
Drug Discovery Today
, vol.15
, pp. 115-120
-
-
Bates, S.1
-
5
-
-
33748787999
-
Pharmacogenetics, drug-metabolizing enzymes, and clinical practice
-
Gardiner SJ, Begg EJ, (2006) Pharmacogenetics, drug-metabolizing enzymes, and clinical practice. Pharmacological reviews 58: 521-590.
-
(2006)
Pharmacological Reviews
, vol.58
, pp. 521-590
-
-
Gardiner, S.J.1
Begg, E.J.2
-
7
-
-
33644647219
-
Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer
-
Bosch TM, Meijerman I, Beijnen JH, Schellens JH, (2006) Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clinical pharmacokinetics 45: 253-285.
-
(2006)
Clinical Pharmacokinetics
, vol.45
, pp. 253-285
-
-
Bosch, T.M.1
Meijerman, I.2
Beijnen, J.H.3
Schellens, J.H.4
-
8
-
-
78651110078
-
Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia
-
Egbelakin A, Ferguson MJ, MacGill EA, Lehmann AS, Topletz AR, et al. (2011) Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia. Pediatric blood & cancer 56: 361-367.
-
(2011)
Pediatric Blood & Cancer
, vol.56
, pp. 361-367
-
-
Egbelakin, A.1
Ferguson, M.J.2
MacGill, E.A.3
Lehmann, A.S.4
Topletz, A.R.5
-
11
-
-
84858699376
-
Effect of CYP2D6 polymorphisms on breast cancer recurrence
-
Morrow PK, Serna R, Broglio K, Pusztai L, Nikoloff DM, et al. (2011) Effect of CYP2D6 polymorphisms on breast cancer recurrence. Cancer.
-
(2011)
Cancer
-
-
Morrow, P.K.1
Serna, R.2
Broglio, K.3
Pusztai, L.4
Nikoloff, D.M.5
-
12
-
-
18344372908
-
The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1
-
Potter GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, et al. (2002) The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. British journal of cancer 86: 774-778.
-
(2002)
British Journal of Cancer
, vol.86
, pp. 774-778
-
-
Potter, G.A.1
Patterson, L.H.2
Wanogho, E.3
Perry, P.J.4
Butler, P.C.5
-
13
-
-
79551623766
-
Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia
-
Lund B, Asberg A, Heyman M, Kanerva J, Harila-Saari A, et al. (2011) Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia. Pediatric blood & cancer 56: 551-559.
-
(2011)
Pediatric Blood & Cancer
, vol.56
, pp. 551-559
-
-
Lund, B.1
Asberg, A.2
Heyman, M.3
Kanerva, J.4
Harila-Saari, A.5
-
14
-
-
78149487509
-
Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study
-
Gor PP, Su HI, Gray RJ, Gimotty PA, Horn M, et al. (2010) Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. Breast cancer research: BCR 12: R26.
-
(2010)
Breast Cancer Research: BCR
, vol.12
-
-
Gor, P.P.1
Su, H.I.2
Gray, R.J.3
Gimotty, P.A.4
Horn, M.5
-
16
-
-
33745177792
-
Cytochrome P450 nomenclature, 2004
-
Nelson DR, (2006) Cytochrome P450 nomenclature, 2004. Methods in molecular biology 320: 1-10.
-
(2006)
Methods in Molecular Biology
, vol.320
, pp. 1-10
-
-
Nelson, D.R.1
-
18
-
-
75549088021
-
The NCBI BioSystems database
-
Geer LY, Marchler-Bauer A, Geer RC, Han L, He J, et al. (2010) The NCBI BioSystems database. Nucleic acids research 38: D492-496.
-
(2010)
Nucleic Acids Research
, vol.38
-
-
Geer, L.Y.1
Marchler-Bauer, A.2
Geer, R.C.3
Han, L.4
He, J.5
-
19
-
-
0033954256
-
The Protein Data Bank
-
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The Protein Data Bank. Nucleic acids research 28: 235-242.
-
(2000)
Nucleic Acids Research
, vol.28
, pp. 235-242
-
-
Berman, H.M.1
Westbrook, J.2
Feng, Z.3
Gilliland, G.4
Bhat, T.N.5
-
20
-
-
0035953739
-
Publishing on the semantic web
-
Berners-Lee T, Hendler J, (2001) Publishing on the semantic web. Nature 410: 1023-1024.
-
(2001)
Nature
, vol.410
, pp. 1023-1024
-
-
Berners-Lee, T.1
Hendler, J.2
-
21
-
-
33747133284
-
Computer science. Creating a science of the Web
-
Berners-Lee T, Hall W, Hendler J, Shadbolt N, Weitzner DJ, (2006) Computer science. Creating a science of the Web. Science 313: 769-771.
-
(2006)
Science
, vol.313
, pp. 769-771
-
-
Berners-Lee, T.1
Hall, W.2
Hendler, J.3
Shadbolt, N.4
Weitzner, D.J.5
-
22
-
-
79957960341
-
Stereoselectivity of human cytochrome p450 in metabolic and inhibitory activities
-
Niwa T, Murayama N, Yamazaki H, (2011) Stereoselectivity of human cytochrome p450 in metabolic and inhibitory activities. Current drug metabolism 12: 549-569.
-
(2011)
Current Drug Metabolism
, vol.12
, pp. 549-569
-
-
Niwa, T.1
Murayama, N.2
Yamazaki, H.3
-
23
-
-
0035204046
-
Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes
-
Baumhakel M, Kasel D, Rao-Schymanski RA, Bocker R, Beckurts KT, et al. (2001) Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes. International journal of clinical pharmacology and therapeutics 39: 517-528.
-
(2001)
International Journal of Clinical Pharmacology and Therapeutics
, vol.39
, pp. 517-528
-
-
Baumhakel, M.1
Kasel, D.2
Rao-Schymanski, R.A.3
Bocker, R.4
Beckurts, K.T.5
-
24
-
-
0027369366
-
Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes
-
Chang TK, Weber GF, Crespi CL, Waxman DJ, (1993) Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer research 53: 5629-5637.
-
(1993)
Cancer Research
, vol.53
, pp. 5629-5637
-
-
Chang, T.K.1
Weber, G.F.2
Crespi, C.L.3
Waxman, D.J.4
-
25
-
-
0030951908
-
Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines
-
Chang TK, Yu L, Maurel P, Waxman DJ, (1997) Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines. Cancer research 57: 1946-1954.
-
(1997)
Cancer Research
, vol.57
, pp. 1946-1954
-
-
Chang, T.K.1
Yu, L.2
Maurel, P.3
Waxman, D.J.4
-
26
-
-
0035987892
-
The effect of cyclophosphamide with and without dexamethasone on cytochrome P450 3A4 and 2B6 in human hepatocytes
-
Lindley C, Hamilton G, McCune JS, Faucette S, Shord SS, et al. (2002) The effect of cyclophosphamide with and without dexamethasone on cytochrome P450 3A4 and 2B6 in human hepatocytes. Drug metabolism and disposition: the biological fate of chemicals 30: 814-822.
-
(2002)
Drug Metabolism and Disposition: The Biological Fate of Chemicals
, vol.30
, pp. 814-822
-
-
Lindley, C.1
Hamilton, G.2
McCune, J.S.3
Faucette, S.4
Shord, S.S.5
-
27
-
-
0033051029
-
Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles
-
Roy P, Yu LJ, Crespi CL, Waxman DJ, (1999) Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles. Drug metabolism and disposition: the biological fate of chemicals 27: 655-666.
-
(1999)
Drug Metabolism and Disposition: The Biological Fate of Chemicals
, vol.27
, pp. 655-666
-
-
Roy, P.1
Yu, L.J.2
Crespi, C.L.3
Waxman, D.J.4
-
28
-
-
3242876326
-
In vitro evaluation of cytochrome P450-mediated drug interactions between cytarabine, idarubicin, itraconazole and caspofungin
-
Colburn DE, Giles FJ, Oladovich D, Smith JA, (2004) In vitro evaluation of cytochrome P450-mediated drug interactions between cytarabine, idarubicin, itraconazole and caspofungin. Hematology 9: 217-221.
-
(2004)
Hematology
, vol.9
, pp. 217-221
-
-
Colburn, D.E.1
Giles, F.J.2
Oladovich, D.3
Smith, J.A.4
-
29
-
-
0038000474
-
Hormonal regulation of the human sterol 27-hydroxylase gene CYP27A1
-
Araya Z, Tang W, Wikvall K, (2003) Hormonal regulation of the human sterol 27-hydroxylase gene CYP27A1. The Biochemical journal 372: 529-534.
-
(2003)
The Biochemical Journal
, vol.372
, pp. 529-534
-
-
Araya, Z.1
Tang, W.2
Wikvall, K.3
-
30
-
-
0030435332
-
Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation
-
Gentile DM, Tomlinson ES, Maggs JL, Park BK, Back DJ, (1996) Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation. The Journal of pharmacology and experimental therapeutics 277: 105-112.
-
(1996)
The Journal of Pharmacology and Experimental Therapeutics
, vol.277
, pp. 105-112
-
-
Gentile, D.M.1
Tomlinson, E.S.2
Maggs, J.L.3
Park, B.K.4
Back, D.J.5
-
31
-
-
0035118826
-
Induction of CYP2C genes in human hepatocytes in primary culture
-
Gerbal-Chaloin S, Pascussi JM, Pichard-Garcia L, Daujat M, Waechter F, et al. (2001) Induction of CYP2C genes in human hepatocytes in primary culture. Drug metabolism and disposition: the biological fate of chemicals 29: 242-251.
-
(2001)
Drug Metabolism and Disposition: The Biological Fate of Chemicals
, vol.29
, pp. 242-251
-
-
Gerbal-Chaloin, S.1
Pascussi, J.M.2
Pichard-Garcia, L.3
Daujat, M.4
Waechter, F.5
-
32
-
-
1542543542
-
Activity and induction of CYP2B, CYP2C, and CYP3A in tissues of cyclophosphane-sensitive and resistant neoplasms and the liver of neoplasm-carrying mice
-
Grishanov A, Kaledin VI, Zueva TV, Nekhoroshkova EK, Nikolin VP, et al. (2003) [Activity and induction of CYP2B, CYP2C, and CYP3A in tissues of cyclophosphane-sensitive and resistant neoplasms and the liver of neoplasm-carrying mice]. Biomeditsinskaia khimiia 49: 27-34.
-
(2003)
Biomeditsinskaia Khimiia
, vol.49
, pp. 27-34
-
-
Grishanov, A.1
Kaledin, V.I.2
Zueva, T.V.3
Nekhoroshkova, E.K.4
Nikolin, V.P.5
-
33
-
-
0034046572
-
Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line
-
Hukkanen J, Lassila A, Paivarinta K, Valanne S, Sarpo S, et al. (2000) Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line. American journal of respiratory cell and molecular biology 22: 360-366.
-
(2000)
American Journal of Respiratory Cell and Molecular Biology
, vol.22
, pp. 360-366
-
-
Hukkanen, J.1
Lassila, A.2
Paivarinta, K.3
Valanne, S.4
Sarpo, S.5
-
34
-
-
21644470890
-
Stimulation of transcriptional expression of human UDP-glucuronosyltransferase 1A1 by dexamethasone
-
Kanou M, Usui T, Ueyama H, Sato H, Ohkubo I, et al. (2004) Stimulation of transcriptional expression of human UDP-glucuronosyltransferase 1A1 by dexamethasone. Molecular biology reports 31: 151-158.
-
(2004)
Molecular Biology Reports
, vol.31
, pp. 151-158
-
-
Kanou, M.1
Usui, T.2
Ueyama, H.3
Sato, H.4
Ohkubo, I.5
-
35
-
-
0037432689
-
Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43
-
Krusekopf S, Roots I, Kleeberg U, (2003) Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43. European journal of pharmacology 466: 7-12.
-
(2003)
European Journal of Pharmacology
, vol.466
, pp. 7-12
-
-
Krusekopf, S.1
Roots, I.2
Kleeberg, U.3
-
36
-
-
0029560982
-
Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability
-
Lampen A, Christians U, Guengerich FP, Watkins PB, Kolars JC, et al. (1995) Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Drug metabolism and disposition: the biological fate of chemicals 23: 1315-1324.
-
(1995)
Drug Metabolism and Disposition: The Biological Fate of Chemicals
, vol.23
, pp. 1315-1324
-
-
Lampen, A.1
Christians, U.2
Guengerich, F.P.3
Watkins, P.B.4
Kolars, J.C.5
-
38
-
-
0027507447
-
Two types of cytochrome P-450(11 beta) in rat adrenals: separate regulation of gene expression
-
Oertle M, Muller J, (1993) Two types of cytochrome P-450(11 beta) in rat adrenals: separate regulation of gene expression. Molecular and cellular endocrinology 91: 201-209.
-
(1993)
Molecular and Cellular Endocrinology
, vol.91
, pp. 201-209
-
-
Oertle, M.1
Muller, J.2
-
39
-
-
0037228554
-
Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone
-
Savas U, Hsu MH, Johnson EF, (2003) Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone. Archives of biochemistry and biophysics 409: 212-220.
-
(2003)
Archives of Biochemistry and Biophysics
, vol.409
, pp. 212-220
-
-
Savas, U.1
Hsu, M.H.2
Johnson, E.F.3
-
40
-
-
0027462225
-
Dexamethasone inhibits corticotropin-induced accumulation of CYP11A and CYP17 messenger RNAs in bovine adrenocortical cells
-
Trzeciak WH, LeHoux JG, Waterman MR, Simpson ER, (1993) Dexamethasone inhibits corticotropin-induced accumulation of CYP11A and CYP17 messenger RNAs in bovine adrenocortical cells. Molecular endocrinology 7: 206-213.
-
(1993)
Molecular Endocrinology
, vol.7
, pp. 206-213
-
-
Trzeciak, W.H.1
LeHoux, J.G.2
Waterman, M.R.3
Simpson, E.R.4
-
41
-
-
62549089278
-
Dexamethasone controls aryl hydrocarbon receptor (AhR)-mediated CYP1A1 and CYP1A2 expression and activity in primary cultures of human hepatocytes
-
Vrzal R, Stejskalova L, Monostory K, Maurel P, Bachleda P, et al. (2009) Dexamethasone controls aryl hydrocarbon receptor (AhR)-mediated CYP1A1 and CYP1A2 expression and activity in primary cultures of human hepatocytes. Chemico-biological interactions 179: 288-296.
-
(2009)
Chemico-Biological Interactions
, vol.179
, pp. 288-296
-
-
Vrzal, R.1
Stejskalova, L.2
Monostory, K.3
Maurel, P.4
Bachleda, P.5
-
42
-
-
33746051348
-
Selective metabolism of vincristine in vitro by CYP3A5
-
Dennison JB, Kulanthaivel P, Barbuch RJ, Renbarger JL, Ehlhardt WJ, et al. (2006) Selective metabolism of vincristine in vitro by CYP3A5. Drug metabolism and disposition: the biological fate of chemicals 34: 1317-1327.
-
(2006)
Drug Metabolism and Disposition: The Biological Fate of Chemicals
, vol.34
, pp. 1317-1327
-
-
Dennison, J.B.1
Kulanthaivel, P.2
Barbuch, R.J.3
Renbarger, J.L.4
Ehlhardt, W.J.5
-
43
-
-
0033398416
-
Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors
-
Villikka K, Kivisto KT, Maenpaa H, Joensuu H, Neuvonen PJ, (1999) Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors. Clinical pharmacology and therapeutics 66: 589-593.
-
(1999)
Clinical Pharmacology and Therapeutics
, vol.66
, pp. 589-593
-
-
Villikka, K.1
Kivisto, K.T.2
Maenpaa, H.3
Joensuu, H.4
Neuvonen, P.J.5
-
44
-
-
0027443019
-
Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions
-
Zhou-Pan XR, Seree E, Zhou XJ, Placidi M, Maurel P, et al. (1993) Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions. Cancer research 53: 5121-5126.
-
(1993)
Cancer Research
, vol.53
, pp. 5121-5126
-
-
Zhou-Pan, X.R.1
Seree, E.2
Zhou, X.J.3
Placidi, M.4
Maurel, P.5
-
45
-
-
35748932937
-
Lack of pharmacokinetic interaction between St. John's wort and prednisone
-
Bell EC, Ravis WR, Chan HM, Lin YJ, (2007) Lack of pharmacokinetic interaction between St. John's wort and prednisone. The Annals of pharmacotherapy 41: 1819-1824.
-
(2007)
The Annals of Pharmacotherapy
, vol.41
, pp. 1819-1824
-
-
Bell, E.C.1
Ravis, W.R.2
Chan, H.M.3
Lin, Y.J.4
-
46
-
-
0032782932
-
Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in adrenalectomized rats
-
Ferron GM, Pyszczynski NA, Jusko WJ, (1999) Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in adrenalectomized rats. Journal of pharmacokinetics and biopharmaceutics 27: 1-21.
-
(1999)
Journal of Pharmacokinetics and Biopharmaceutics
, vol.27
, pp. 1-21
-
-
Ferron, G.M.1
Pyszczynski, N.A.2
Jusko, W.J.3
-
47
-
-
0142067563
-
Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor
-
Usui T, Saitoh Y, Komada F, (2003) Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. Biological & pharmaceutical bulletin 26: 510-517.
-
(2003)
Biological & Pharmaceutical Bulletin
, vol.26
, pp. 510-517
-
-
Usui, T.1
Saitoh, Y.2
Komada, F.3
-
48
-
-
0036252316
-
In vitro metabolic characteristics of cytochrome P-450 2A6 in Chinese liver microsomes
-
Xia XY, Peng RX, Yu JP, Wang H, Wang J, (2002) In vitro metabolic characteristics of cytochrome P-450 2A6 in Chinese liver microsomes. Acta pharmacologica Sinica 23: 471-476.
-
(2002)
Acta Pharmacologica Sinica
, vol.23
, pp. 471-476
-
-
Xia, X.Y.1
Peng, R.X.2
Yu, J.P.3
Wang, H.4
Wang, J.5
-
49
-
-
0032790040
-
Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N-dechloroethylation of trofosfamide
-
May-Manke A, Kroemer H, Hempel G, Bohnenstengel F, Hohenlochter B, et al. (1999) Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N-dechloroethylation of trofosfamide. Cancer chemotherapy and pharmacology 44: 327-334.
-
(1999)
Cancer Chemotherapy and Pharmacology
, vol.44
, pp. 327-334
-
-
May-Manke, A.1
Kroemer, H.2
Hempel, G.3
Bohnenstengel, F.4
Hohenlochter, B.5
-
50
-
-
0027415546
-
Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Metabolic drug interactions
-
Zhou XJ, Zhou-Pan XR, Gauthier T, Placidi M, Maurel P, et al. (1993) Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Metabolic drug interactions. Biochemical pharmacology 45: 853-861.
-
(1993)
Biochemical Pharmacology
, vol.45
, pp. 853-861
-
-
Zhou, X.J.1
Zhou-Pan, X.R.2
Gauthier, T.3
Placidi, M.4
Maurel, P.5
|